Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 3841 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  Implantica AG

Manipal Hospital Varthur Road Commemorates World Kidney Day 2024 with Exclusive Event for Senior Citizens

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024

Contact The Gross Law Firm by April 15, 2024 Deadline to Join Class Action Against InMode Ltd.(INMD)

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  InMode Ltd.

Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 9, 2024 to Discuss Your Rights - AMLX

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  Amylyx Pharmaceuticals, Inc.

Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  Kodiak Sciences Inc.

Combat Arms Earplugs Settlement Moves to Final Resolution

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  3M Corporation

Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  Cardinal Health

BioLineRx Reports 2023 Financial Results and Recent Corporate and Portfolio Updates

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024

IONETIX announces appointment of Douglas Boothe to Board of Directors

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  Ionetix Corporation

Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  Viking Therapeutics, Inc.

Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  Quest Diagnostics, Inc.

STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  STORM Therapeutics Ltd

Research published in Journal of the American Chemical Society highlights potential of HIF Inhibition as a therapeutic approach for cancers

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  Curve Therapeutics Ltd.

Chondroitin Sulfate for Pet Supplements Market - Forecasts from 2024 to 2029, Featuring Unibridge, Shandong Haiyu Biological Co., ZPD, Shandong Runxin Biotechnology Co. and Bioiberica

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024

Digital Diagnostics Market to reach over USD 6.32 Bn by the year 2031 - Exclusive Report by InsightAce Analytic

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024

Asceneuron Joins Critical Path for Alzheimer's Disease Consortium

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024
Related companies:  Asceneuron SA

Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024

Veeda Clinical Research Acquires European CRO - Heads - Expanding Global Reach & Capabilities

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2024

United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aG

Read more ››
By: GlobeNewswire - 26 Mar 2024
Related companies:  Mesoblast Limited

CARBIOS joins Paris Good Fashion to accelerate textile circularity and contribute to more sustainable fashion

Read more ››
By: GlobeNewswire - 26 Mar 2024
Related companies:  Carbios SA
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑